Antibodies to EphA3

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9290571
SERIAL NO

14143427

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The current invention relates to high-affinity antibodies to EphA3 that have reduced immunogenicity when administered to a human to treat diseases and method of using such antibodies.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
HUMANIGEN INC533 AIRPORT BOULEVARD SUITE 400 BURLINGAME CA 94010

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Bebbington, Christopher R San Mateo, US 51 738
Luehrsen, Kenneth Half Moon Bay, US 14 103
Martinez, David Sunnyvale, US 34 288
Yarranton, Geoffrey T Burlingame, US 45 626
Yi, Christina South San Francisco, US 7 30

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Sep 22, 2027
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00